These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 21894771

  • 1. [Multidisciplinary assessment of effects, safety and procedure of whole lung lavage for 8 patients with autoimmune pulmonary alveolar proteinosis].
    Sugimoto C, Arai T, Nishiyama A, Inoue Y, Kagawa T, Akira M, Matsumuro A, Hirose M, Kitaichi M, Hayashi S, Inoue Y.
    Nihon Kokyuki Gakkai Zasshi; 2011 Aug; 49(8):569-76. PubMed ID: 21894771
    [Abstract] [Full Text] [Related]

  • 2. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
    Campo I, Carey BC, Paracchini E, Kadija Z, De Silvestri A, Rodi G, De Amici M, Torre C, Zorzetto M, Griese M, Meloni F, Corsico AG, Trapnell BC, Mariani F.
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 37973175
    [Abstract] [Full Text] [Related]

  • 3. Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases.
    Ohkouchi S, Akasaka K, Ichiwata T, Hisata S, Iijima H, Takada T, Tsukada H, Nakayama H, Machiya JI, Irokawa T, Ogawa H, Shibata Y, Ichinose M, Ebina M, Nukiwa T, Kurosawa H, Nakata K, Tazawa R.
    Ann Am Thorac Soc; 2017 Aug; 14(8):1298-1304. PubMed ID: 28421817
    [Abstract] [Full Text] [Related]

  • 4. Plasmapheresis for treatment of pulmonary alveolar proteinosis.
    Luisetti M, Rodi G, Perotti C, Campo I, Mariani F, Pozzi E, Trapnell BC.
    Eur Respir J; 2009 May; 33(5):1220-2. PubMed ID: 19407056
    [Abstract] [Full Text] [Related]

  • 5. [Patient with autoimmune alveolar proteinosis who did not respond to GM-CSF inhalation therapy and underwent repeated whole-lung lavage].
    Ueda Y, Matsuo K, Tsushima M, Mizuta M, Fujiwara K, Yonei T, Sato T.
    Nihon Kokyuki Gakkai Zasshi; 2009 Sep; 47(9):833-8. PubMed ID: 19827590
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
    Yamamoto H, Yamaguchi E, Agata H, Kandatsu N, Komatsu T, Kawai S, Baba K, Awaya T, Nishikomori R, Tsurusawa M, Nakata K.
    Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Whole-lung lavage: a successful treatment for restoring acinar ventilation distribution in primary acquired pulmonary alveolar proteinosis.
    Vanderhelst E, Hanon S, Verbanck S, Schuermans D, Wissing K, Bonella F, Vincken W.
    Respiration; 2012 Aug; 84(1):70-4. PubMed ID: 22627079
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode.
    Yanagisawa A, Takimoto T, Shintani R, Kobayashi T, Hirose M, Arai T, Inoue Y.
    Intern Med; 2023 Aug 01; 62(15):2237-2241. PubMed ID: 37164675
    [Abstract] [Full Text] [Related]

  • 13. Experience with treatment of pulmonary alveolar proteinosis from a tertiary care centre in north India.
    Khan A, Agarwal R, Aggarwal AN, Bal A, Sen I, Yaddanapuddi LN, Puri GD.
    Indian J Chest Dis Allied Sci; 2012 Aug 01; 54(2):91-7. PubMed ID: 22973777
    [Abstract] [Full Text] [Related]

  • 14. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R.
    Respir Med; 2012 Feb 01; 106(2):284-93. PubMed ID: 22112784
    [Abstract] [Full Text] [Related]

  • 15. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis.
    Wylam ME, Ten R, Prakash UB, Nadrous HF, Clawson ML, Anderson PM.
    Eur Respir J; 2006 Mar 01; 27(3):585-93. PubMed ID: 16507860
    [Abstract] [Full Text] [Related]

  • 16. Bilateral whole lung lavage in pulmonary alveolar proteinosis--a retrospective study.
    Silva A, Moreto A, Pinho C, Magalhães A, Morais A, Fiuza C.
    Rev Port Pneumol; 2014 Mar 01; 20(5):254-9. PubMed ID: 25042291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan.
    Inoue Y, Nakata K, Arai T, Tazawa R, Hamano E, Nukiwa T, Kudo K, Keicho N, Hizawa N, Yamaguchi E, Eda R, Oishi K, Maeda Y, Koreeda Y, Kodo N, Sakatani M.
    Respirology; 2006 Jan 01; 11 Suppl():S55-60. PubMed ID: 16423273
    [Abstract] [Full Text] [Related]

  • 20. Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis.
    Bonella F, Bauer PC, Griese M, Wessendorf TE, Guzman J, Costabel U.
    Eur Respir J; 2012 Dec 01; 40(6):1468-74. PubMed ID: 22496317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.